Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation

Blood

Volumn 100, Issue 7, 2002, Pages 2367-2373

  Henter, Jan Inge ^{a,b,c,d,e,f,g,h,i,j,k,l}   Samuelsson Horne, AnnaCarin ^{a,b,c,d,e,f,g,h,i,j,k}   Aricò, Maurizio ^{a,b,c,d,e,f,g,h,i,j,k}   Maarten Egeler, R ^{a,b,c,d,e,f,g,h,i,j,k}   Elinder, Göran ^{a,b,c,d,e,f,g,h,i,j,k}   Filipovich, Alexandra H ^{a,b,c,d,e,f,g,h,i,j,k}   Gadner, Helmut ^{a,b,c,d,e,f,g,h,i,j,k}   Imashuku, Shinsaku ^{a,b,c,d,e,f,g,h,i,j,k}   Komp, Diane ^{a,b,c,d,e,f,g,h,i,j,k}   Ladisch, Stephan ^{a,b,c,d,e,f,g,h,i,j,k}   Webb, David ^{a,b,c,d,e,f,g,h,i,j,k}   Janka, Gritta ^{a,b,c,d,e,f,g,h,i,j,k}  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c Ospedale dei Bambini G Di Cristina   (Italy)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f ST ANNA CHILDREN S HOSPITAL   (Austria)

^g KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Children's Research Institute   (United States)

^j GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BUSULFAN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; METHOTREXATE; THYMOCYTE ANTIBODY;

ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL PROTOCOL; ERYTHROPHAGOCYTOSIS; FEMALE; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036786375     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0172     Document Type: Article

References (46)

1. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr. 1983;140:221-230.
2. Arico M, Janka G, Fischer A, et al. Hemophagocytic lymphohistiocytosis: diagnosis, treatment and prognostic factors: report of 122 children from the international registry. Leukemia. 1996;10:197-203.
3. Henter J-I, Arico M, Elinder G, Imashuku S, Janka G. Familial hemophagocytic lymphohistiocytosis (primary HLH). Hematol/Oncol Clin North Am. 1998;12:417-433.
4. Henter J-I, Elinder G, Ost A, and the FHL Study Group of the Histiocyte Society. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol. 1991;18:29-33.
5. Egeler RM, Shapiro RS, Loechelt B, Filipovich AH. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediat Hematol Onc. 1996;18:340-345.
6. Henter J-I, Elinder G. Cerebromeningeal hemophagocytic lymphohistiocytosis. Lancet. 1992;339:104-107.
7. Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood. 1997;89:794-800.
8. Henter J-I, Nennesmo I. Neuropathological findings and neurological symptoms in 23 children with hemophagocytic lymphohistiocytosis. J Pediatr. 1997;130:358-365.
9. Henter J-I, Söder O, Ost Å, Elinder G. Incidence and clinical features of familial hemophagocytic lymphohistiocytosis in Sweden. Acta Paediatr Scand. 1991;80:428-435.
10. Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood. 1989;73:2128-2132.
11. Howells DW, Strobel S, Smith I, Levinsky RJ, Hyland K. Central nervous system involvement in the erythrophagocytic disorders of infancy: the role of cerebrospinal fluid neopterins in their differential diagnosis and clinical management. Pediatr Res. 1990;28:116-119.
12. Henter J-I, Sbder O, Hansson M, Elinder G, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood. 1991;78:2918-2922.
13. Imashuku S, Ikushima S, Esumi N, et al. Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndrome. Leukemia Lymphoma. 1991;3:287-292.
14. Henter J-I, Andersson B, Elinder G, Jakobson Å, Lübeck P-O, Söder O. Elevated circulating IL-1 receptor antagonist but not IL-1 agonists in familial hemophagocytic lymphohistiocytosis. Med Pediatr Oncol. 1996;27:21-25.
15. Fadeel B, Orrenius S, Henter J-I. Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients. Brit J Haematol. 1999;106:406-415.
16. Ohadi M, Lalloz MR, Sham P, et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet. 1999;64:165-171.
17. Dufourcq-Lagelouse R, Jabado N, Le Deist F, et al. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. Am J Hum Genet. 1999;64:172-179.
18. Graham GE, Graham LM, Bridge PJ, et al. Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis. Pediatr Res. 2000;48:227-232.
19. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957-1959.
20. Göransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet. 2001;68:590-597
21. Clementi R, zur Stadt U, Savoldi G, et al. Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. J Med Genet. 2001;38:643-646.
22. Fadeel B, Orrenius S, Henter J-I. Familial hemophagocytic lymphohistiocytosis: too little cell death may seriously damage your health. Leuk Lymphoma. 2001;42:13-20.
23. Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol. 2001;114:761-769.
24. Arico M, Imashuku S, Clementi R, et al. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Blood. 2001;97:1131-1133.
25. Ambruso DR, Hays T, Zwartjes WJ, Tubergen DG, Favara BE. Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213. Cancer. 1980;45:2516-2520.
26. Fischer A, Virelizier JL, Arenzana-Seisdedos F, Perez A, Nezelof G, Griscelli C. Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate and cranial irradiation. Pediatrics. 1985;76:263-268.
27. Henter J-I, Elinder G, Finkel Y, Söder O. Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis. Lancet. 1986;2:1402.
28. Stephan JL, Donadieu J, Le Deist F, Blanche S, Griscelli C, Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids and cyclosporin A. Blood. 1993;82:2319-2323.
29. Fischer A, Cerf-Bensussan N, Blanche S, et al. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr. 1986;108:267-270.
30. Blanche S, Caniglia M, Girault D, Landman J, Griscelli C, Fischer A. Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: a single center study of 22 cases. Blood. 1991;78:51-54.
31. Todo S, Fujiwara F, Ikushima S, et al. Allogeneic bone marrow transplantation for familial erythrophagocytic lymphohistiocytosis with high dose VP16-containing conditioning regimen. Leukemia Lymphoma. 1990;1:361-364.
32. Nespoli L, Locatelli F, Bonetti F, et al. Familial hemophagocytic lymphohistiocytosis treated with allogeneic bone marrow transplantation. Bone Marrow Transplant. 1991;7(suppl 3):139-142.
33. Henter J-I, Elinder G. Familial hemophagocytic lymphohistiocytosis: clinical review based on the findings in seven children. Acta Paediatr Scand. 1991;80:269-277.
34. Henter J-I, Arico M, Egeler M, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol. 1997;28:342-347.
35. Janka G, Elinder G, Imashuku S, Schneider M, Henter J-I. Infection- and malignancy-associated hemophagocytic syndromes: secondary hemophagocytic lymphohistiocytosis. Hematol/Oncol Clin North Am. 1998;12:435-444.
36. Henter J-I, Ehrnst A, Andersson J, Elinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr. 1993;82:369-372.
37. Baker KS, DeLaat CA, Steinbuch M, et al. Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood. 1997;89:3857-3863.
38. Jabado N, de Graeff-Meeder ER, Cavazzana-Calvo M, et al. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood. 1997;90:4743-4748.
39. Imashuku S; Hibi S, Todo S, et al. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant. 1999;23:569-572.
40. Dürken M, Horstmann M, Bieling P, et al. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients. Br J Haematol. 1999;106:1052-1058.
41. Imashuku S, Hibi S, Ohara T, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood. 1999;93:1869-1874.
42. Martinsson P, Liminga G, Nygren P, Larsson R. Characteristics of etoposide-induced apoptotic cell death in the U-937 human lymphoma cell line. Anticancer Drugs. 2001;12:699-705.
43. Pui C-H, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. New Engl J Med. 1991;325:1632-1687.
44. Henter J-I, Elinder G, Lübeck P-O, Öst A. Myelodysplastic syndrome following epipodophyllotoxin therapy in familial lymphohistocytosis. Pediatr Hematol Oncol. 1993;10:163-168.
45. Kitazawa J, Ito E, Arai K, Yokoyama M, Fukayama M, Imashuku S. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Med Pediatr Oncol. 2001;37:153-154.
46. Henter J-I. Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis. Med Pediatr Oncol. 2002;38:305-309.